New combo therapy may help people with multiple food allergies eat more foods safely

NCT ID NCT03679676

First seen Jun 08, 2026 · Last updated Jun 13, 2026 · Updated 1 time

Summary

This study tested whether adding a biologic drug to oral immunotherapy (OIT) helps people with allergies to peanut and one or two other foods tolerate larger amounts of those foods without severe reactions. 130 participants aged 4 to 55 with confirmed allergies to 2 or 3 foods (including peanut) took part. The goal was to see if more people could safely eat at least 1,043 mg of peanut protein and other allergens after treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HYPERSENSITIVITY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Sean N. Parker Center for Allergy & Asthma Research at Stanford University

    Palo Alto, California, 94304, United States

  • University of California Los Angeles (UCLA)

    Los Angeles, California, 90095, United States

  • University of California San Diego (UCSD)

    San Diego, California, 92123, United States

Conditions

Explore the condition pages connected to this study.

Conditions inferred from the trial description

These were inferred from the trial's summary, not listed by the trial registrant.